A comparative study of plasma concentrations of liposomal amphotericin B (L-AMP-LRC-1) in adults, children and neonates (Q43983887)

28 November 2017

A comparative study of plasma concentrations of liposomal amphotericin B (L-AMP-LRC-1) in adults, children and neonates (English)

1 reference

28 November 2017

1 reference

Rajshree N Kotwani

1

1 reference

28 November 2017

Prafulla C Gokhale

2

1 reference

28 November 2017

Prashant V Bodhe

3

1 reference

28 November 2017

Babita G Kirodian

4

1 reference

28 November 2017

Nilima A Kshirsagar

5

1 reference

28 November 2017

Sunil K Pandya

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

International Journal of Pharmaceutics

28 November 2017

1 reference

28 November 2017

238

1 reference

28 November 2017

1-2

1 reference

28 November 2017

11-15

1 reference

Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Treatment of murine candidosis and cryptococcosis with a unilamellar liposomal amphotericin B formulation (AmBisome)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Amphotericin B Pharmacokinetics in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Candida endophthalmitis in the premature infant

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

A pharmacologic guide to the clinical use of amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Pharmacokinetics of amphotericin B in children

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

AmBisome (liposomal amphotericin B): a comparative review.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Pharmacokinetics and tolerance of liposomal amphotericin B in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Successful treatment of disseminated candidiasis resistant to amphotericin B by liposomal amphotericin B: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Quantitation of amphotericin B with use of high-pressure liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Pharmacokinetics of amphotericin B in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900066-2

7 January 2021

10.1016/S0378-5173(02)00066-2

Identifiers

DOI

1 reference

28 November 2017

1 reference